629 related articles for article (PubMed ID: 22981763)
1. Differences in avidity of IgG antibodies to pertussis toxin after acellular pertussis booster vaccination and natural infection.
Barkoff AM; Gröndahl-Yli-Hannuksela K; Vuononvirta J; Mertsola J; Kallonen T; He Q
Vaccine; 2012 Nov; 30(48):6897-902. PubMed ID: 22981763
[TBL] [Abstract][Full Text] [Related]
2. Differences of IgG antibody avidity after an acellular pertussis (aP) booster in adolescents after a whole cell (wcP) or aP primary vaccination.
Prelog M; Almanzar G; Rieber N; Ottensmeier B; Zlamy M; Liese J
Vaccine; 2013 Jan; 31(2):387-93. PubMed ID: 23142306
[TBL] [Abstract][Full Text] [Related]
3. Age-related differences in antibody avidities to pertussis toxin and filamentous hemagglutinin in a healthy Japanese population.
Fumimoto R; Otsuka N; Sunagawa T; Tanaka-Taya K; Kamiya H; Kamachi K
Vaccine; 2019 Apr; 37(18):2463-2469. PubMed ID: 30930008
[TBL] [Abstract][Full Text] [Related]
4. Enhanced memory B-cell immune responses after a second acellular pertussis booster vaccination in children 9 years of age.
Hendrikx LH; Felderhof MK; Oztürk K; de Rond LG; van Houten MA; Sanders EA; Berbers GA; Buisman AM
Vaccine; 2011 Dec; 30(1):51-8. PubMed ID: 22064265
[TBL] [Abstract][Full Text] [Related]
5. Modelling anti-pertussis toxin IgG antibody decay following primary and preschool vaccination with an acellular pertussis vaccine in UK subjects using a modified oral fluid assay.
Fry NK; Litt DJ; Duncan J; Vaghji L; Warrener L; Samuel D; Andrews N; Harnden A; Harrison TG
J Med Microbiol; 2013 Sep; 62(Pt 9):1281-1289. PubMed ID: 23722435
[TBL] [Abstract][Full Text] [Related]
6. IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content.
Hendrikx LH; Berbers GA; Veenhoven RH; Sanders EA; Buisman AM
Vaccine; 2009 Nov; 27(47):6530-6. PubMed ID: 19729085
[TBL] [Abstract][Full Text] [Related]
7. Anti-pertussis toxin IgG and anti-filamentous hemagglutinin IgG production in children immunized with pertussis acellular vaccine and comparison of these titers with the sera of pertussis convalescent children.
Sato Y; Sato H
Dev Biol Stand; 1985; 61():367-72. PubMed ID: 3835079
[TBL] [Abstract][Full Text] [Related]
8. Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age.
Wood N; McIntyre P; Marshall H; Roberton D
Pediatr Infect Dis J; 2010 Mar; 29(3):209-15. PubMed ID: 20009964
[TBL] [Abstract][Full Text] [Related]
9. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection.
Hallander HO; Ljungman M; Jahnmatz M; Storsaeter J; Nilsson L; Gustafsson L
APMIS; 2009 Sep; 117(9):660-71. PubMed ID: 19703126
[TBL] [Abstract][Full Text] [Related]
10. Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with Bordetella pertussis in young children.
Hallander HO; Ljungman M; Storsaeter J; Gustafsson L
APMIS; 2009 Nov; 117(11):797-807. PubMed ID: 19845530
[TBL] [Abstract][Full Text] [Related]
11. Pertussis antitoxin decay after vaccination with DTPa. Response to a first booster dose 3 1/2-6 1/2 years after the third vaccine dose.
Hallander HO; Gustafsson L; Ljungman M; Storsaeter J
Vaccine; 2005 Nov; 23(46-47):5359-64. PubMed ID: 16051400
[TBL] [Abstract][Full Text] [Related]
12. Differential T- and B-cell responses to pertussis in acellular vaccine-primed versus whole-cell vaccine-primed children 2 years after preschool acellular booster vaccination.
Schure RM; Hendrikx LH; de Rond LG; Oztürk K; Sanders EA; Berbers GA; Buisman AM
Clin Vaccine Immunol; 2013 Sep; 20(9):1388-95. PubMed ID: 23825195
[TBL] [Abstract][Full Text] [Related]
13. Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine.
Dalby T; Petersen JW; Harboe ZB; Krogfelt KA
J Med Microbiol; 2010 Sep; 59(Pt 9):1029-1036. PubMed ID: 20508003
[TBL] [Abstract][Full Text] [Related]
14. Boosting Teenagers With Acellular Pertussis Vaccines Containing Recombinant or Chemically Inactivated Pertussis Toxin: A Randomized Clinical Trial.
Blanchard Rohner G; Chatzis O; Chinwangso P; Rohr M; Grillet S; Salomon C; Lemaître B; Boonrak P; Lawpoolsri S; Clutterbuck E; Poredi IK; Wijagkanalan W; Spiegel J; Pham HT; Viviani S; Siegrist CA
Clin Infect Dis; 2019 Mar; 68(7):1213-1222. PubMed ID: 30759183
[TBL] [Abstract][Full Text] [Related]
15. Antibody avidity to pertussis toxin after acellular pertussis vaccination and infection.
Knuutila A; Dalby T; Ahvenainen N; Barkoff AM; Jørgensen CS; Fuursted K; Mertsola J; He Q
Emerg Microbes Infect; 2023 Dec; 12(1):e2174782. PubMed ID: 36715361
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of Bordetella pertussis specific Immunoglobulin G antibody levels among asymptomatic individuals aged 4 to 24 years: a descriptive cross sectional study from Sri Lanka.
Sigera S; Perera J; Rasarathinam J; Samaranayake D; Ediriweera D
BMC Infect Dis; 2016 Dec; 16(1):729. PubMed ID: 27905894
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Timing of Tetanus-Diphtheria-Acellular Pertussis Vaccine Administration in Pregnancy on the Avidity of Pertussis Antibodies.
Abu-Raya B; Giles ML; Kollmann TR; Sadarangani M
Front Immunol; 2019; 10():2423. PubMed ID: 31681310
[No Abstract] [Full Text] [Related]
18. Anti-pertussis antibody kinetics following DTaP-IPV booster vaccination in Norwegian children 7-8 years of age.
Aase A; Herstad TK; Jørgensen SB; Leegaard TM; Berbers G; Steinbakk M; Aaberge I
Vaccine; 2014 Oct; 32(45):5931-6. PubMed ID: 25218299
[TBL] [Abstract][Full Text] [Related]
19. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age.
Hendrikx LH; de Rond LG; Oztürk K; Veenhoven RH; Sanders EA; Berbers GA; Buisman AM
Vaccine; 2011 Aug; 29(34):5725-30. PubMed ID: 21669247
[TBL] [Abstract][Full Text] [Related]
20. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough.
Winsnes R; Lønnes T; Møgster B; Berdal BP
Dev Biol Stand; 1985; 61():353-65. PubMed ID: 2872124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
